132 results
Page 5 of 7
8-K
EX-1.1
hc6k2f928
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am
424B5
rj7sicwgz8oi26w9 vwp
28 Jul 20
Prospectus supplement for primary offering
4:17pm
8-K
EX-99.1
4yl7ih0
24 Jul 20
Israel secures rights to stockpile and reserve doses of LUNAR-COV19 for its citizens
6:02am
8-K
h9z70astzrkxian0e
24 Jul 20
Israel secures rights to stockpile and reserve doses of LUNAR-COV19 for its citizens
6:02am
8-K
cw9ekp vreiofci
18 Jun 20
Regulation FD Disclosure
1:15pm
8-K
EX-99.1
3wzuh2 8a
21 May 20
Ultragenyx Announces Exercise of Option to Purchase Additional Stock of Arcturus Therapeutics
4:34pm
8-K
EX-99.1
f1wvjme3h ug
7 May 20
Arcturus Therapeutics Announces First Quarter 2020 Financial
4:08pm
8-K
mghd257elf7k friggm1
7 May 20
Arcturus Therapeutics Announces First Quarter 2020 Financial
4:08pm
424B5
e76irh2r5h1m
17 Apr 20
Prospectus supplement for primary offering
4:02pm
8-K
EX-1.1
okrtmzf
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
424B5
3cypa
15 Apr 20
Prospectus supplement for primary offering
4:14pm
8-K
EX-10.1
v6oug8 raq
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
424B5
a4plfli5ao40uo8we
27 Mar 20
Prospectus supplement for primary offering
5:19pm
10-K
ntcswxo
16 Mar 20
Annual report
11:09am
10-K
EX-10.1
qml m6ekz3sno
16 Mar 20
Annual report
11:09am
8-K
e4ofttbf4p2mdzl
11 Mar 20
Arcturus Therapeutics Reports Fourth Quarter and Year End 2019 Financial Results
4:05pm